Skip to main content

Table 3 Kansas City Cardiomyopathy Questionnaire results summary for each of the assessment domains and global KCCQ score according to NYHA functional class

From: Quality of life status determinants in hypertrophic cardiomyopathy as evaluated by the Kansas City Cardiomyopathy Questionnaire

Variable NYHA I median (min, max) NYHA II median (min, max) NYHA III median (min, max) P Jonckheere–Tepstra Pairwise posttest comparissons
Physical limitation 95.8
(41.6–100)
64.5
(0–100)
50
(25–87.5)
0.001 1–2: p = 0.002
1–3: p = 0.001
Symptom frequency 100
(52–100)
75
(20.8–100)
64.5
(39.5–100)
0.001 1–2: p = 0.001
1–3: p = 0.001
Quality of life 87.5
(12.5–100)
50
(12.5–100)
50
(12.5–100)
0.002 1–3: p = 0.004
1–2: p = 0.018
Social limitation 100
(8.3–100)
75
(0–100)
50
(8.3–100)
0.002 1–3: p = 0.003
Global KCCQ 90.6
(35.9–100)
65.6
(19.4–100)
57.2
(30.7–88.5)
0.001 1–3: p = 0.001
1–2: p = 0.002
  1. NYHA New York Heart Association, KCCQ Kansas City Cardiomyopathy Questionnaire